Effect of community-based standardized management in patients with coronary heart disease accompanied by anxiety and depression

CHEN Jun-ping

doi:10.3969/j.1674-4055.2015.04.10

Abstract：Objective To observe the effect of community-based standardized management in patients with coronary heart disease (CHD) accompanied by anxiety and depression. Methods The patients with CHD accompanied by anxiety and depression (n=96, male 54, female 42, aged from 36 to 72 and average age=53.2 ±9.3) were chosen from 6 communities from Jan. 2009 to Dec. 2012. The patients were divided, according to registration order, into control group and observation group (each n=48) by using random digital table. The control group was only given drug therapy and observation group, drug therapy combining community-based standardized management. The control rate of clinical indexes, scores of self-rating depressive scale (SDS) and self-rating anxiety scale (SAS), and follow-up situation were compared between 2 groups. Results The control rates of body mass index (BMI), blood pressure (BP), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C) and high-density lipoprotein-cholesterol (HDL-C) were significantly higher in observation group than those in control group (P<0.05). The scores of SDS and SAS decreased in 2 groups after treatment (all P<0.05). After treatment, the scores of SDS and SAS decreased significantly in observation group compared with control group [(41.3± 4.7) vs. (50.8±4.5)] and [(38.9±3.8) vs. (48.3±4.5), all P<0.05]. In observation group, follow-up management rate, rate of taking drugs regularly and control rate increased significantly, and missing rate decreased significantly compared with control group (all P<0.05). Conclusion Community-based standardized management can improve the control rate of clinical indexes, and relieve symptoms of anxiety and depression in patients with CHD accompanied by anxiety and depression, which is worth to be popularized in clinic.